Finance

Beta
Lists
095700:KOSDAQ
Genexine Inc
â‚©2,975.00
-1.16%
(-35.00) 1D
Jun 10, 3:15:42 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 095700...
Open
â‚©3,010
High
â‚©3,085
Low
â‚©2,910
Mkt. cap
135.48B
Avg. vol.
367.65K
Volume
118.86K
52-wk high
â‚©7,490
52-wk low
â‚©2,815
EPS
-â‚©456
Shares outstanding
45.54M
No. of employees
70
Open
â‚©3,010
High
â‚©3,085
Low
â‚©2,910
Mkt. cap
135.48B
Avg. vol.
367.65K
Volume
118.86K
52-wk high
â‚©7,490
52-wk low
â‚©2,815
EPS
-â‚©456
Shares outstanding
45.54M
No. of employees
70
News stories
From sources across the web
About Genexine Inc
CEOYoung Chul Sung
Employees70
Founded1999
Headquarters-
SectorBiotechnology
Websitegenexine.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2021
Dec 2021
Sep 2023
Mar 2024
Revenue
-
-
357.04M
2.07B
Cost of goods sold
-
-
-
2.35B
Cost of revenue
-
-
-
2.35B
Research and development expenses
-
-
-
7.86B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
2.50B
Operating expense
-
-
-
12.37B
Total operating expenses
-
-
-
14.72B
Operating income
-
-
-
-12.64B
Other non operating income
-
-
-
275.19M
EBT including unusual items
-
-
-
-11.57B
EBT excluding unusual items
-
-
-
-12.06B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
1.59B
Net income
-
-
-
-11.57B
Net profit margin
-
-
-
-557.86%
Earnings per share
-
-
-590.00
-
Interest and investment income
-
-
-
309.59M
Interest expense
-
-
-
-639.11M
Net interest expenses
-
-
-
-329.52M
Depreciation and amortization charges
-
-
-
374.54M
EBITDA
-
-
-
-11.37B
Gain or loss from assets sale
-
-
-
17.89M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer